Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Sientra, Inc. Identifier:
First received: May 18, 2009
Last updated: May 5, 2017
Last verified: May 2017
Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.

Condition Intervention
Breast Augmentation
Breast Reconstruction
Breast Revision
Device: Silimed Gel-Filled Mammary Implant

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: Sientra Sponsored Silimed Gel-Filled Mammary Implant Clinical Study Protocol: Core Clinical Investigation

Resource links provided by NLM:

Further study details as provided by Sientra, Inc.:

Primary Outcome Measures:
  • Local complications [ Time Frame: 10 Years ]

Secondary Outcome Measures:
  • Satisfaction determined by patients [ Time Frame: 10 Years ]

Enrollment: 1788
Study Start Date: November 2002
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Primary Augmentation
Silimed Gel-Filled Mammary Implant
Device: Silimed Gel-Filled Mammary Implant
Experimental: Primary Reconstruction
Silimed Gel-Filled Mammary Implant
Device: Silimed Gel-Filled Mammary Implant
Experimental: Revison
Silimed Gel-Filled Mammary Implant
Device: Silimed Gel-Filled Mammary Implant


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria

Subjects are admitted into the study only if all of the following eligibility is true:

  • Female
  • Age limitation specific to the indication:

    • Primary Augmentation: Must be 18 years or older
    • Primary Reconstruction: No age limit
    • Revision: If original surgery was primary reconstruction, then no age limit. If original surgery was primary augmentation, then must be 18 years or older.
  • Adequate tissue available to cover implant(s)
  • Willingness to follow study requirements (informed consent form, follow-up visits)
  • Candidate for primary augmentation, primary reconstruction, or revision

Exclusion Criteria

Subjects are not eligible if any of the following criteria exist:

  • Advanced fibrocystic disease, considered to be pre-malignant without mastectomy
  • Inadequate or unsuitable tissue
  • Active infection in the body at the time of surgery
  • Pregnant or lactating
  • Medical condition that might result in unduly high surgical risk and/or significant postoperative complications, in the judgment of the Investigator
  • Use of drugs, including any drug that would interfere with blood clotting, that might result in high risk and/or significant postoperative complications
  • Demonstrated psychological characteristics that are unrealistic or unreasonable given the risks involved with the surgical procedure
  • Determination by physical examination that the subject does have any connective tissue/autoimmune disorder
  • Existing carcinoma of the breast without accompanying mastectomy
  • MRI scan is prohibited because of implanted metal device, claustrophobia, or other condition.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00905645

United States, California
Sientra, Inc.
Santa Barbara, California, United States, 93117
Sponsors and Collaborators
Sientra, Inc.